Company intelligence / Profile preview

Munich Re

Munich, Bavaria, Germanymunichre.com ↗

Ownership: Private
Employees: ~43584
Development stage: Commercial

Overview

Munich Re provides reinsurance and specialty insurance products globally. Its new Life Science Liability coverage addresses the unique risks of pharmaceutical, biotech, medical device, clinical trial sponsors, dietary supplement manufacturers and related companies. The company publishes industry reports on trends in healthcare and life sciences but does not itself conduct drug development or clinical trials. In June 2025, its North American division launched dedicated liability coverage for the life sciences sector. It has no pipeline of drugs or therapies.

Industry: Investors

Partnerships

Not specified for pharma/biotech partnerships; partners with insurers and reinsurers worldwide.

Beyond the preview

Go deeper on Munich Re.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Munich Re.

Explore the full profile